TABLE 5

Enhancement of Sxlf7,M1/Sxlf9; +/P{snf+} ovary disintegration by reduction in maternal and/or zygotic tra+ dose

Maternal tra genotypeZygotic tra genotypeOogenic mutant ovaries per female (n = 100 females each)Relative viability
CrossaTwo (%)One (%)None (%)%NREF
1+/++/+998282691
2trav2/++/+099173297
2trav2/+trav2/+0010057294
  • Virgins for crosses 1 and 2 were from the cross w cm Sxlf7,M1 ct/Binsinscy, y w snx2B; trav2 kar ry red/P{EPgy2 w+mC}EY04597 ☿☿ × ♂♂ w cm Sxlf7,M1 ct/Y; trav2 kar ry red/P{EPgy2 w+mC}EY04597. The marker P{EPgy2 w+mC}EY04597 is only 15 kb from tra.

  • a Cross 1: w cm Sxlf7,M1 ct/Binsinscy, y w snx2B; P{EPgy2 w+mC}EY04597/P{EPgy2 w+mC}EY04597 ☿☿ × ♂♂ y w cm Sxlf9/Y; P{snf+ w+mC}19 and cross 2: w cm Sxlf7,M1 ct/Binsinscy, y w snx2B; trav2/P{EPgy2 w+mC}EY04597 ☿☿ × ♂♂ y w cm Sxlf9/Y; P{snf+ w+mC}19.